integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
ILUYFTWKNLJHOS-BJTCJBOMSA-N
DG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
ILUYFTWKNLJHOS-BJTCJBOMSA-N
CHEBI:88789
0 Reactome links
3 studies
3
Observed studies
3
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
ILUYFTWKNLJHOS-BJTCJBOMSA-N
InChI Key
ILUYFTWKNLJHOS-BJTCJBOMSA-N
IUPAC name
Preferred name
DG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
INN name
—
Synonym
(2S)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate
ChEBI
CHEBI:88789
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
Observed in differential profiles
non_COVID_19_healthy_vs_non_critical_COVID_19
G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
G1_Ctrl_vs_G2_Ab